Study populations for period analyses of cancer survival

British Journal of Cancer

Volumn 108, Issue 3, 2013, Pages 699-707

  Jansen, L ^a   Hakulinen, T ^b   Brenner, H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b FINNISH CANCER REGISTRY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ANALYTIC METHOD; ARTICLE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER SURVIVAL; COHORT ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; PERIOD ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL;

AGE FACTORS; COHORT STUDIES; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASMS; PROGNOSIS; REGISTRIES; SURVIVAL RATE; TIME FACTORS;

EID: 84875231190     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.14     Document Type: Article

References (25)

1. Brenner H, Gefeller O (1996) An alternative approach to monitoring cancer patient survival. Cancer 78(9): 2004-2010.
2. Brenner H, Gefeller O, Hakulinen T (2002a) A computer program for period analysis of cancer patient survival. Eur J Cancer 38(5): 690-695.
3. Brenner H, Hakulinen T (2002a) Up-to-date long-term survival curves of patients with cancer by period analysis. J Clin Oncol 20(3): 826-832.
4. Brenner H, Hakulinen T (2002b) Very-long-term survival rates of patients with cancer. J Clin Oncol 20(21): 4405-4409.
5. Brenner H, Holleczek B (2011) Deriving valid population-based cancer survival estimates in the presence of nonnegligible proportions of cancers notified by death certificates only. Cancer Epidemiol Biomarkers Prev 20(12): 2480-2486.
6. Brenner H, Soderman B, Hakulinen T (2002b) Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370 000 cancer patients in Finland. Int J Epidemiol 31(2): 456-462.
7. Chen T, Jansen L, Gondos A, Ressing M, Holleczek B, Katalinic A, Brenner H. GEKID Cancer Survival Working Group (2012) Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage. BMC Cancer 12(1): 128.
8. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377(9760): 127-138.
9. Corazziari I, Quinn M, Capocaccia R (2004) Standard cancer patient population for age standardising survival ratios. Eur J Cancer 40(15): 2307-2316.
10. Ederer F, Heise H (1959) Instructions to IBM 650 programmers in processing survival computations. National Cancer Institute: Bethesda (MD).
11. Ellison LF (2006) An empirical evaluation of period survival analysis using data from the Canadian Cancer Registry. Ann Epidemiol 16(3): 191-196.
12. Ellison LF, Pogany L, Mery LS (2007) Childhood and adolescent cancer survival: a period analysis of data from the Canadian Cancer Registry. Eur J Cancer 43(13): 1967-1975.
13. Gondos A, Arndt V, Holleczek B, Stegmaier C, Ziegler H, Brenner H (2007) Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis. Int J Cancer 121(2): 395-400.
14. Gondos A, Bray F, Hakulinen T, Brenner H (2009) Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol 20(3): 564-573.
15. Hakulinen T, Seppa K, Lambert PC (2011) Choosing the relative survival method for cancer survival estimation. Eur J Cancer 47(14): 2202-2210.
16. Henson DE, Ries LA (1995) The relative survival rate. Cancer 76(10): 1687-1688.
17. Pollack LA, Li J, Berkowitz Z, Weir HK, Wu XC, Ajani UA, Ekwueme DU, Li C, Pollack BP (2011) Melanoma survival in the United States, 1992 to 2005. J Am Acad Dermatol 65(5 Suppl 1): S78-S86.
18. Quaglia A, Tavilla A, Shack L, Brenner H, Janssen-Heijnen M, Allemani C, Colonna M, Grande E, Grosclaude P, Vercelli M (2009) The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer 45(6): 1006-1016.
19. Redaniel MT, Laudico A, Mirasol-Lumague MR, Gondos A, Uy GL, Toral JA, Benavides D, Brenner H (2009) Ovarian cancer survival population differences: a 'high resolution study' comparing Philippine residents, and Filipino-Americans and Caucasians living in the US. BMC Cancer 9: 340.
20. Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG, Law SC, Ahn YO, Xiang YB, Yeole BB, Shin HR, Shanta V, Woo ZH, Martin N, Sumitsawan Y, Sriplung H, Barboza AO, Eser S, Nene BM, Suwanrungruang K, Jayalekshmi P, Dikshit R, Wabinga H, Esteban DB, Laudico A, Bhurgri Y, Bah E, Al-Hamdan N (2010) Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 11(2): 165-173.
21. Storm HH, Engholm G, Hakulinen T, Tryggvadottir L, Klint A, Gislum M, Kejs AM, Bray F (2010) Survival of patients diagnosed with cancer in the Nordic countries up to 1999-2003 followed to the end of 2006. A critical overview of the results. Acta Oncol 49(5): 532-544.
22. Talback M, Stenbeck M, Rosen M (2004) Up-to-date long-term survival of cancer patients: an evaluation of period analysis on Swedish Cancer Registry data. Eur J Cancer 40(9): 1361-1372.
23. van de Schans SA, Gondos A, van Spronsen DJ, Rachtan J, Holleczek B, Zanetti R, Coebergh JW, Janssen-Heijnen ML, Brenner H (2011) Improving relative survival, but large remaining differences in survival for non-Hodgkin's lymphoma across Europe and the United States from 1990 to 2004. J Clin Oncol 29(2): 192-199.
24. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I (2007) Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 8(9): 784-796.
25. Verdecchia A, Guzzinati S, Francisci S, De Angelis R, Bray F, Allemani C, Tavilla A, Santaquilani M, Sant M (2009) Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer 45(6): 1042-1066.